Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jeroen J.W.M Janssen"'
Autor:
Camille C.B. Kockerols, Jeroen J.W.M Janssen, Nicole M.A. Blijlevens, Saskia K. Klein, Laura G.M. van Hussen-Daenen, Gwendolyn G.Y. van Gorkom, Willem M. Smit, Peter van Balen, Bart J. Biemond, Marjan J. Cruijsen, Maarten F. Corsten, Peter A.W. te Boekhorst, Harry R. Koene, Geerte L. van Sluis, Jan J. Cornelissen, Peter E. Westerweel
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/339bc2e6e77449b99514307759bf809b
Autor:
Noortje van Gils, Han J.M.P. Verhagen, Michaël Broux, Tania Martiáñez, Fedor Denkers, Eline Vermue, Arjo Rutten, Tamás Csikós, Sofie Demeyer, Meryem Çil, Marjon Al, Jan Cools, Jeroen J.W.M. Janssen, Gert J. Ossenkoppele, Renee X. Menezes, Linda Smit
Publikováno v:
iScience, Vol 25, Iss 9, Pp 105013- (2022)
Summary: Although chemotherapy induces complete remission in the majority of acute myeloid leukemia (AML) patients, many face a relapse. This relapse is caused by survival of chemotherapy-resistant leukemia (stem) cells (measurable residual disease;
Externí odkaz:
https://doaj.org/article/84ab3dd633704ce3b8af11a7a4647841
Autor:
Dietger Niederwieser, Dirk Hasenclever, Wolfgang E. Berdel, Bart J. Biemond, Haifa Kathrin Al-Ali, Yves Chalandon, Michel Van Gelder, Christian Junghanss, Goesta Gahrton, Mathias Haenel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen J.W.M. Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jakob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Peter JM Valk, Bob Lowenberg, Jan J. Cornelissen
Publikováno v:
Blood. 140:2126-2129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54fc73dfad3387acaa0e6311028d8a55
https://doi.org/10.1182/blood-2022-157684
https://doi.org/10.1182/blood-2022-157684
Autor:
Tobias B. Polak, Joost Van Rosmalen, Stijn Dirven, Julia K. Herzig, Jacqueline Cloos, Soheil Meshinchi, Konstanze Döhner, Jeroen J.W.M. Janssen, David G.J. Cucchi
Publikováno v:
Haematologica, 107(10), 2506-2510. Ferrata Storti Foundation
Polak, T B, van Rosmalen, J, Dirven, S, Herzig, J K, Cloos, J, Meshinchi, S, Döhner, K, Janssen, J J W M & Cucchi, D G J 2022, ' Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia : a systematic review and meta-analysis ', Haematologica, vol. 107, no. 10, pp. 2506-2510 . https://doi.org/10.3324/haematol.2022.281218, https://doi.org/10.3324/haematol.2022.281218
Polak, T B, van Rosmalen, J, Dirven, S, Herzig, J K, Cloos, J, Meshinchi, S, Döhner, K, Janssen, J J W M & Cucchi, D G J 2022, ' Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia : a systematic review and meta-analysis ', Haematologica, vol. 107, no. 10, pp. 2506-2510 . https://doi.org/10.3324/haematol.2022.281218, https://doi.org/10.3324/haematol.2022.281218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0d8ecbc92ed99869cb7c84018c4903
https://doi.org/10.3324/haematol.2022.281218
https://doi.org/10.3324/haematol.2022.281218
Autor:
Inge G.P. Geelen, Stein-Erik Gullaksen, Mette M. Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter, Nicole M.A. Blijlevens, Willem M. Smit, Bjorn T. Gjertsen, Tobias Gedde-Dahl, Berit Markevärn, Malika M.A. Koppes, Peter E. Westerweel, Henrik Hjorth-Hansen, Jeroen J.W.M. Janssen
Publikováno v:
Annals of Hematology, 102(6), 1395-1408. Springer Verlag
Annals of Hematology, 102, 6, pp. 1395-1408
Geelen, I G P, Gullaksen, S-E, Ilander, M M, Olssen-Strömberg, U, Mustjoki, S, Richter, J, Blijlevens, N M A, Smit, W M, Gjertsen, B T, Gedde-Dahl, T, Markevärn, B, Koppes, M M A, Westerweel, P E, Hjorth-Hansen, H & Janssen, J J W M 2023, ' Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response : clinical and immunological effects ', Annals of Hematology, vol. 102, no. 6, pp. 1395-1408 . https://doi.org/10.1007/s00277-023-05199-1
Annals of Hematology, 102, 6, pp. 1395-1408
Geelen, I G P, Gullaksen, S-E, Ilander, M M, Olssen-Strömberg, U, Mustjoki, S, Richter, J, Blijlevens, N M A, Smit, W M, Gjertsen, B T, Gedde-Dahl, T, Markevärn, B, Koppes, M M A, Westerweel, P E, Hjorth-Hansen, H & Janssen, J J W M 2023, ' Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response : clinical and immunological effects ', Annals of Hematology, vol. 102, no. 6, pp. 1395-1408 . https://doi.org/10.1007/s00277-023-05199-1
In order to improve molecular response for a discontinuation attempt in chronic myeloid leukemia (CML) patients in chronic phase, who had not achieved at least a molecular response IS (MR 4.0) after at least 2 years of imatinib therapy, we prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ccc3c9777b8e81ed1a850d02fc25862
https://research.vumc.nl/en/publications/328bbec1-473e-4573-8f5b-d581ac5ae885
https://research.vumc.nl/en/publications/328bbec1-473e-4573-8f5b-d581ac5ae885
Autor:
Man Wai Tang, Deborah van der Tuin, Mesire Aydin, Jarom Heijmans, Arjan A. van de Loosdrecht, Ellen Meijer, Caroline E. Rutten, Marielle Wondergem, Jeroen J.W.M. Janssen, Marjolein Donker, Mette D. Hazenberg, Sonja Zweegman, Bart J. Biemond, David C. de Leeuw, Erfan Nur
Publikováno v:
Blood. 140:3287-3289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8083e72416610c0d6a2eb29ca4c3200
https://doi.org/10.1182/blood-2022-163042
https://doi.org/10.1182/blood-2022-163042
Autor:
Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A.M. Hofland, Mona M.H.E Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J. Scholten, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Dimitri A. Breems, Thomas Fischer, Bjørn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan A. Maertens, Markus G Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Patrycja Gradowska, Bob Lowenberg, David C. de Leeuw, Jeroen J.W.M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos
Publikováno v:
Blood. 140:9125-9127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b89429da6da5b4ee004c3c3b45a3ce7d
https://doi.org/10.1182/blood-2022-157753
https://doi.org/10.1182/blood-2022-157753
Autor:
Jesse M. Tettero, Lok Lam Ngai, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjørn Tore Gjertsen, Patrycja Gradowska, Laimonas Griskevicius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan A. Maertens, Markus G Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter JM Valk, Bob Lowenberg, Gert J. Ossenkoppele, Jacqueline Cloos
Publikováno v:
Blood. 140:2027-2029
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::395a3f9de6bcc3b10d91c423f90acbb5
https://doi.org/10.1182/blood-2022-157009
https://doi.org/10.1182/blood-2022-157009
Autor:
Camille C.B. Kockerols, Inge G.P. Geelen, Mark-David Levin, Jeroen J.W.M. Janssen, Berna H. Beveloo, Avinash G. Dinmohamed, Mels Hoogendoorn, Jan J. Cornelissen, Peter E. Westerweel
Publikováno v:
Haematologica.
Not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dacb03bdc436dddda52ec8f902ca892
https://doi.org/10.3324/haematol.2022.282447
https://doi.org/10.3324/haematol.2022.282447
Autor:
Han J.M.P. Verhagen, Noortje van Gils, Tania Martiañez, Anna van Rhenen, Arjo Rutten, Fedor Denkers, David C. de Leeuw, Marjon A. Smit, Mei-Ling Tsui, Louise L.E. de Vos Klootwijk, Renee X. Menezes, Meyram Çil, Margaretha G.M. Roemer, Eline Vermue, Stan Heukelom, Sonja Zweegman, Jeroen J.W.M. Janssen, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Linda Smit
Publikováno v:
Cell Reports, Vol 25, Iss 11, Pp 3021-3035.e5 (2018)
Summary: Leukemic stem cells (LSCs) are thought to be the major cause of the recurrence of acute myeloid leukemia (AML) due to their potential for self-renewal. To identify therapeutic strategies targeting LSCs, while sparing healthy hematopoietic st
Externí odkaz:
https://doaj.org/article/786323a84cf84b2ca5db63b64d5ff6a0